Clin2
NCT07657520Likely a fitWithdrawn

High-Altitude Brain Health Study

Multiple System Atrophy

Part of Brain & nervous system, Lungs & breathing clinical trials.

This study follows healthy Han Chinese adults living at high altitudes to see how the brain changes over time. It may help learn why some people develop Parkinson's disease or other movement problems.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Ages
40 years to 75 years
Study type
Observational

Who can take part

  • You are of Han Chinese ethnicity.
  • You are between 40 and 75 years old.
  • You have lived at the study location for at least one year.
  • You have never been diagnosed with Parkinson's disease or a similar movement disorder.
  • You do not have severe chronic lung or heart disease.
  • You are able to give informed consent and do not have significant memory or thinking problems.

0

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07644013Recruiting
Multiple System Atrophy Registry Study in China

This study is collecting information from patients with multiple system atrophy (a rare neurological condition affecting movement and body functions), Parkinson disease, and healthy volunteers to better understand these conditions. By participating, you help doctors learn more about how these diseases develop and progress.

Beijing, Beijing Municipality
NCT03872102Recruiting
Brain imaging study to track Parkinson-related disease changes

This study uses brain scans and clinical check-ins to better diagnose and predict how Parkinson-related conditions may progress over time. It may help researchers find markers that explain why symptoms change, and could improve future care.

Dallas, Texas
NCT07353463Recruiting
Parkinson's and MSA study with biosamples and imaging

This study collects data from people with Parkinson's disease or multiple system atrophy (MSA) to better understand these conditions. You will have blood, saliva, optional spinal fluid tests, and brain scans (MRI, PET/SPECT).

Shanghai
NCT07476352Not yet recruiting· Early Phase 1
Testing ALT001 for Multiple System Atrophy

This early-phase trial tests a new drug called ALT001 for people with multiple system atrophy (MSA). It aims to see if the drug is safe and may help slow the disease.

Beijing, Beijing Municipality
NCT06596746Recruiting
Tracking markers for neurodegenerative diseases

This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.

Cassino, Frosinone
NCT06645626Recruiting
Health service use and quality of life in atypical Parkinson's

This study looks at how people with certain rare brain conditions (like progressive supranuclear palsy, corticobasal syndrome, or multiple system atrophy) use healthcare services and how their quality of life is affected. It may help doctors better support patients and their carers.

Southampton, Hampshire

Hear when a new Multiple System Atrophy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.